4//SEC Filing
Trujillo Carlos 4
Accession 0001683168-23-008432
CIK 0001157075other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:01 PM ET
Size
5.5 KB
Accession
0001683168-23-008432
Insider Transaction Report
Form 4
Trujillo Carlos
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2023-11-20+85,000→ 85,000 totalExercise: $2.18Exp: 2033-11-20→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The options vest 50% on November 20, 2023 and 50% on November 20, 2024.
Documents
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeother
Related Parties
1- filerCIK 0001464520
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 5:01 PM ET
- Size
- 5.5 KB